These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10092007

  • 41. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.
    Vaccine; 2013 Apr 26; 31(18):2302-9. PubMed ID: 23499593
    [Abstract] [Full Text] [Related]

  • 42. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G.
    Vaccine; 2013 Jul 18; 31(33):3327-32. PubMed ID: 23735678
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M, Li J, Wang H, Yang M, Zhang Y, Zhou L, Wei H, Yang G, Yu Y, Wei X, Yu Y, Wang L, Wan M.
    Biotechnol Lett; 2012 May 18; 34(5):839-47. PubMed ID: 22286179
    [Abstract] [Full Text] [Related]

  • 46. Prospects, including time-frames, for improved foot and mouth disease vaccines.
    Grubman MJ, Mason PW.
    Rev Sci Tech; 2002 Dec 18; 21(3):589-600. PubMed ID: 12523699
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Engineering better vaccines for foot-and-mouth disease.
    Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ.
    Dev Biol (Basel); 2003 Dec 18; 114():79-88. PubMed ID: 14677679
    [Abstract] [Full Text] [Related]

  • 49. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.
    Ramírez-Carvajal L, Díaz-San Segundo F, Hickman D, Long CR, Zhu J, Rodríguez LL, de los Santos T.
    J Virol; 2014 Oct 18; 88(19):11140-53. PubMed ID: 25031341
    [Abstract] [Full Text] [Related]

  • 50. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S, Kit M, DiMarchi RD, Little SP, Gale C.
    Arch Virol; 1991 Oct 18; 120(1-2):1-17. PubMed ID: 1718244
    [Abstract] [Full Text] [Related]

  • 51. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
    Eschbaumer M, Stenfeldt C, Rekant SI, Pacheco JM, Hartwig EJ, Smoliga GR, Kenney MA, Golde WT, Rodriguez LL, Arzt J.
    BMC Vet Res; 2016 Sep 15; 12():205. PubMed ID: 27634113
    [Abstract] [Full Text] [Related]

  • 52. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME, El-Deeb AH, Zeidan SM, Hussein HA, Abu-El-Naga HI.
    Vet Microbiol; 2017 Oct 15; 210():1-7. PubMed ID: 29103677
    [Abstract] [Full Text] [Related]

  • 53. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD, Moore DM, Morgan DO, Robertson BH, Callis JJ, Kleid DG, Shire SJ, Yansura DG, Dowbenko D, Small B.
    Am J Vet Res; 1985 Mar 15; 46(3):587-90. PubMed ID: 2986495
    [Abstract] [Full Text] [Related]

  • 54. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
    Kit S, Kit M, DiMarchi R, Little S, Gale C.
    Adv Exp Med Biol; 1991 Mar 15; 303():211-20. PubMed ID: 1725233
    [No Abstract] [Full Text] [Related]

  • 55. Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant.
    Sadir AM, Zamorano PI, Romera A, Wigdorovitz A, Smitsaart E, Marangunich L, Schiappacassi C, Borca MV.
    Vet Immunol Immunopathol; 1999 Jul 01; 69(1):11-22. PubMed ID: 10490231
    [Abstract] [Full Text] [Related]

  • 56. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
    Zamorano P, Wigdorovitz A, Chaher MT, Fernandez FM, Carrillo C, Marcovecchio FE, Sadir AM, Borca MV.
    Virology; 1994 Jun 01; 201(2):383-7. PubMed ID: 8184548
    [Abstract] [Full Text] [Related]

  • 57. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J, Yang L, Xu H, Zhang Y, Wan M, Liu G, Zhao L, Wang L, Yu Y.
    Vaccine; 2011 Oct 19; 29(45):7960-5. PubMed ID: 21872635
    [Abstract] [Full Text] [Related]

  • 58. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F.
    Prog Vet Microbiol Immunol; 1987 Oct 19; 3():59-72. PubMed ID: 2483918
    [No Abstract] [Full Text] [Related]

  • 59. Foot-and-mouth disease. Challenge of cattle after multiple vaccinations.
    Straub OC.
    Comp Immunol Microbiol Infect Dis; 1995 Sep 19; 18(4):253-7. PubMed ID: 8549114
    [Abstract] [Full Text] [Related]

  • 60. FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle.
    Li Z, Yin X, Yi Y, Li X, Li B, Lan X, Zhang Z, Liu J.
    Vet Microbiol; 2011 Apr 21; 149(1-2):99-103. PubMed ID: 21109368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.